Martina Beltramello
Bellinzona, TI, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.
Journal: bioRxiv : the preprint server for biology
Published: January 30, 2023
Neutralization, effector function and immune imprinting of Omicron variants.
Journal: Nature
Published: January 17, 2023
Broad betacoronavirus neutralization by a stem helix-specific human antibody.
Journal: Science (New York, N.Y.)
Published: August 04, 2021
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody.
Journal: bioRxiv : the preprint server for biology
Published: April 14, 2021
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape.
Journal: bioRxiv : the preprint server for biology
Published: April 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.
Journal: Nature
Published: March 29, 2021
Broad sarbecovirus neutralization by a human monoclonal antibody.
Journal: Nature
Published: March 29, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
Journal: bioRxiv : the preprint server for biology
Published: January 20, 2021
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
Journal: Cell
Published: January 07, 2021
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.
Journal: Science (New York, N.Y.)
Published: August 14, 2020
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Journal: Cell
Published: August 03, 2020
Last Updated: 09/26/2026